ClinicalTrials.govpublic full text
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors
advanced cancer, bms-986218, nivolumab, ipilimumab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981917
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.